These findings indicated that hepatic-specific deletion of Glut9 could indeed relieve GSDMD-mediated pyroptosis and NASH by reducing the intrahepatic UA content. The gene discussed is GSDMD; the disease is metabolic dysfunction-associated steatohepatitis.